NYADERM 100000 UNIT — DIN 00716871
NYSTATIN : 100000 UNIT · TARO PHARMACEUTICALS INC · CREAM · wholesale supply in Canada
Health Canada status: MARKETED
What is NYADERM?
NYADERM 100000 UNIT contains NYSTATIN : 100000 UNIT. It is listed in the Health Canada Drug Product Database under DIN 00716871, held by TARO PHARMACEUTICALS INC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as marketed, status dated 31-Dec-1979. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
How much does Nystatin cost around the world?
Nystatin is listed on 2 of the national price registers Nexara ingests. Each country publishes on a different basis, so figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Austria publishes a KVP (Kassenverkaufspreis); Luxembourg publishes a reimbursement. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed |
|---|---|---|---|
| Austria | KVP (Kassenverkaufspreis) | 5 | 8 |
| Luxembourg | reimbursement | 2 | 2 |
10 pack listings across 7 brand entries and 2 price bases, refreshed 05 Sep 2026. Ranges span every Nystatin pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Nystatin in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
7 holders have a Canadian DIN containing Nystatin, across 12 DINs, of which 1 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TARO PHARMACEUTICALS INC | 2 | 1 | NYADERM, NYADERM ONT 100000UNIT/GM | Sourceable in Canada |
| LAB NADEAU LTÉE, DIVISION OF TECHNILAB INC. | 2 | 0 | NADOSTINE CRM 100000IU/GM, NADOSTINE ONT 100000IU/GM | No marketed DIN |
| LEDERLE CYANAMID CANADA INC. | 2 | 0 | NILSTAT TOP CRM 100000UNIT/GM, NILSTAT TOP ONT 100000UNIT/GM | No marketed DIN |
| SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | 2 | 0 | MYCOSTATIN CRM 100000UNIT/GM, MYCOSTATIN ONT 100000IU/GM | No marketed DIN |
| TEVA CANADA LIMITED | 2 | 0 | RATIO-NYSTATIN | No marketed DIN |
| BRISTOL-MYERS SQUIBB CANADA | 1 | 0 | CANDISTATIN TOPICAL POWDER - 100000 UNIT/G | No marketed DIN |
| CONVATEC, DIVISION OF BRISTOL-MYERS SQUIBB CANADA CO. | 1 | 0 | MYCOSTATIN TOPICAL PWR 100,000UNITS/GM | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100000 UNIT |
|---|---|
| Dosage form | CREAM |
| Route | TOPICAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Nystatin |
|---|---|
| ATC code | D01AA01 |
| AHFS class | 84:04.08.28 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00716871 |
|---|---|
| DIN (unpadded, as printed on some documents) | 716871 |
| Brand name | NYADERM |
| Generic / active ingredient | NYSTATIN : 100000 UNIT |
| Market authorization holder | TARO PHARMACEUTICALS INC |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D01AA01 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D01AA |
| Current status | MARKETED |
| Status date | 31-Dec-1979 |
| Original market date | 1979-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
1 of 12 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| CANDISTATIN TOPICAL POWDER - 100000 UNIT/G | 100000 UNIT | POWDER | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | 02195704 |
| MYCOSTATIN CRM 100000UNIT/GM | 100000 UNIT | CREAM | SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | 00029092 |
| MYCOSTATIN ONT 100000IU/GM | 100000 UNIT | OINTMENT | SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | 00029556 |
| MYCOSTATIN TOPICAL PWR 100,000UNITS/GM | 100000 UNIT | POWDER | CONVATEC, DIVISION OF BRISTOL-MYERS SQUIBB CANADA CO. | CANCELLED POST MARKET | 02004674 |
| NADOSTINE CRM 100000IU/GM | 100000 UNIT | CREAM | LAB NADEAU LTÉE, DIVISION OF TECHNILAB INC. | CANCELLED POST MARKET | 00288217 |
| NADOSTINE ONT 100000IU/GM | 100000 UNIT | OINTMENT | LAB NADEAU LTÉE, DIVISION OF TECHNILAB INC. | CANCELLED POST MARKET | 00288195 |
| NILSTAT TOP CRM 100000UNIT/GM | 100000 UNIT | CREAM | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | 00449792 |
| NILSTAT TOP ONT 100000UNIT/GM | 100000 UNIT | OINTMENT | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | 00449806 |
| NYADERM ONT 100000UNIT/GM | 100000 UNIT | OINTMENT | TARO PHARMACEUTICALS INC | CANCELLED POST MARKET | 00716898 |
| RATIO-NYSTATIN | 100000 UNIT | OINTMENT | TEVA CANADA LIMITED | CANCELLED POST MARKET | 02194228 |
2 · Same class — other molecules in ATC D01AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Nystatin | CANDISTATIN TOPICAL POWDER - 100000 UNIT/G · MYCOSTATIN CRM 100000UNIT/GM · MYCOSTATIN ONT 100000IU/GM · MYCOSTATIN TOPICAL PWR 100,000UNITS/GM · +7 more | 12 | 1 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC D01A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| D01AE | Butenafine · Chlorphenesin · Ciclopirox · Combinations · Methylrosaniline · +4 more | 91 | 17 |
| D01AC | Clotrimazole · Econazole · Efinaconazole · Imidazoles/Triazoles In Combination With Corticosteroids · Ketoconazole · +3 more | 31 | 12 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is NYADERM called?
Also recorded in Canada as: nystatin 1000000 UNT Oral Capsule [Bio-Statin] (US), nystatin 500000 UNT Oral Capsule [Bio-Statin] (US), nystatin 100 UNT/MG Topical Powder [Nystop] (US), nystatin 100 UNT/MG Topical Powder [Nyamyc] (US), nystatin 100 UNT/MG / triamcinolone acetonide 0.001 MG/MG Topical Ointment (US), nystatin 100000 UNT/ML / triamcinolone acetonide 1 MG/ML Topical Cream (US), neomycin 0.025 MG/MG / nystatin 100 UNT/MG / thiostrepton 2.5 UNT/MG / triamcinolone 0.001 MG/MG Topical Ointment (US), nystatin 1000000 UNT Oral Capsule (US), nystatin 100000 UNT/ML / tolnaftate 10 MG/ML Topical Cream (US), nystatin 100000 UNT/ML Oral Suspension (US), nystatin 200000 UNT Oral Lozenge (US), nystatin 500000 UNT Oral Capsule (US), nystatin 500000 UNT Oral Tablet (US), nystatin 0.1 UNT/MG Topical Ointment (US), nystatin 100000 UNT/ML Topical Cream (US).
The same molecule, Nystatin, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Mycostatin Filmtabl. | Latin | Austria |
| Mycostatin orale Susp. | Latin | Austria |
| Mycostatin Zinkoxidpaste | Latin | Austria |
| Candio Hermal soft Paste | Latin | Austria |
| Mycostatin Salbe | Latin | Austria |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
What is Nystatin called in other languages?
Buyers, prescribers and procurement teams outside Canada often search for the ingredient in their own script. These are phonetic renderings of the ingredient name Nystatin, published to help those searches reach this page.
| Language | Nystatin |
|---|---|
| Arabic العربية | نيستاتين |
| Chinese (Simplified) 简体中文 | 制霉菌素 |
| Russian Русский | Нистатин |
| Spanish Español | Nistatina |
| French Français | Nystatine |
| Portuguese Português | Nistatina |
| Japanese 日本語 | ナイスタチン |
These are transliterations of the ingredient name, generated automatically and published only where two independent checks agreed. They are not registered local trade names and carry no marketing authorisation in any market. Always confirm a product against its local registration before ordering.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.